Moreover, enhanced physician confidence and guideline support for wider therapeutic applications propel earlier adoption in a large number of healthcare facilities and payer systems, worldwide
Since the sequence homology between exenatide and human GLP-1 is only 53%, 40% to 60% of patients develop antiexenatide antibodies, though in most cases antibody development does not reduce the efficacy of exenatide treatment [44,49-51]
Dong Y, Carty J, Goldstein N, He Z, Hwang E, Chau D
and Gaynor, P
Products: Red Bean + Ceramide, Vitamin C + Niacinamide, Rice + Glutathione, Snail + Hyaluronic Acid, Cherry Blossom + Panthenol, Fresh Peach + Peptide, PDRN + Collagen 1CTN MoCRA, CPNP, CNF, ANVISA EXW,FOB South Korea
Diabetes affects 24 million people in the United States